White Marvin L
SEC insider (Form 3/4/5 filer). CIK 0001493324. Executive Chair at Aptevo Therapeutics Inc. (APVO) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in SEATTLE, WA.
Companies White Marvin L has filed insider reports for
- Aptevo Therapeutics Inc. (APVO): Director, Officer, Executive Chair
- Emergent BioSolutions Inc. (EBS): Director
White Marvin L
CIK: 0001493324
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 6, 2026APVO
Aptevo Therapeutics Inc.
Tax PaymentDirect406 shares at avg. $4.07$2K - Aug 6, 2026APVO
Aptevo Therapeutics Inc.
ExerciseDirect1.7K shares- - Jul 17, 2026APVO
Aptevo Therapeutics Inc.
ExerciseDirect1 shares- - Apr 30, 2026EBS
Emergent BioSolutions Inc.
AwardDirect25.3K shares- - Aug 6, 2025APVO
Aptevo Therapeutics Inc.
AwardDirectRestricted Stock Unit
30K shares- - Jul 17, 2025APVO
Aptevo Therapeutics Inc.
ExerciseDirect10 shares- - Apr 30, 2025EBS
Emergent BioSolutions Inc.
AwardDirect34.4K shares- - Mar 3, 2025APVO
Aptevo Therapeutics Inc.
ExerciseDirect6 shares- - Mar 2, 2025APVO
Aptevo Therapeutics Inc.
ExerciseDirect8 shares- - Nov 11, 2024EBS
Emergent BioSolutions Inc.
SaleDirect14.3K shares at avg. $11.97$171K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 |  APVO Aptevo Therapeutics Inc. | Tax Payment | 406 | $4.07 | $1,652 | Direct |
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | Exercise | 1,666 | - | $0 | Direct |
| Jul 17, 2026 | APVO Aptevo Therapeutics Inc. | Exercise | 1 | - | $0 | Direct |
| Apr 30, 2026 |  EBS Emergent BioSolutions Inc. | Award | 25,344 | - | $0 | Direct |
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | Award Restricted Stock Unit | 30,000 | - | - | Direct |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | Exercise | 10 | - | - | Direct |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | Award | 34,403 | - | - | Direct |
| Mar 3, 2025 | APVO Aptevo Therapeutics Inc. | Exercise | 6 | - | - | Direct |
| Mar 2, 2025 | APVO Aptevo Therapeutics Inc. | Exercise | 8 | - | - | Direct |
| Nov 11, 2024 | EBS Emergent BioSolutions Inc. | Sale | 14,287 | $11.97 | $171,015 | Direct |
1-10 of 10 transactions